Skip to main content
Caplight Logo









Creo

Creo

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://creoingredients.com

Last Round

VC Round

Sep 29, 2020

Company Overview

Creo operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a VC Round in September 2020.

Creo is a biotechnology company that produces rare and novel cannabinoid ingredients using a proprietary fermentation-based platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Creo Comparables

Compare Creo with similar companies based on industry and business-model similarity.

Creo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomedican
89%
PhytoCell Biotech
87%
Demetrix
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Creo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 29, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Roy Lipski

CEO and Co-founder

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 29, 2020

    $50M raised in a VC Round.

Book a demo to see all signals

For institutional investors. Book with your work email.

Creo Filings

Explore SEC and related filing metadata, where available.

Creo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Creo's valuation, stock price, and market status.

Is Creo a public or private company?

Creo is a private company.

What is the current stock price of Creo?

Creo is a private company, so its shares have no public market price. Caplight tracks Creo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Creo worth (valuation)?

Valuation information for Creo is not publicly available.

Can I buy Creo stock?

Creo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Creo's last funding round?

Creo's most recent funding round was VC Round on September 29, 2020.

Who are the main investors in Creo?

Investor information for Creo is not publicly disclosed.

Will Creo IPO soon?

No public IPO plans have been announced for Creo.

How can I track Creo secondary market activity?

Caplight tracks bids, offers, and trades in Creo's shares on secondary markets.

Firmographic Details

HeadquartersSan Diego, California
Employee Range9
Year Founded2016
Last FundingSep 29, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?